We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
+$199M
Cap. Flow
+$164M
Cap. Flow %
12.92%
Top 10 Hldgs %
54.41%
Holding
79
New
19
Increased
11
Reduced
13
Closed
25

Top Buys

Rank Stock Value
1
CTVA icon
Corteva
CTVA
+$45.7M
2
CCJ icon
Cameco
CCJ
+$45.1M
3
BG icon
Bunge Global
BG
+$37.3M
4
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$34M
5
VLO icon
Valero Energy
VLO
+$26.3M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$48.2M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$38.4M
3
BERY
Berry Global Group, Inc.
BERY
+$37.8M
4
HRTX icon
Heron Therapeutics
HRTX
+$36.7M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$36.4M

Sector Composition

Rank Sector Weight
1 Healthcare 13.71%
2 Technology 12.43%
3 Industrials 11.49%
4 Energy 9.77%
5 Materials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXMD icon
26
TherapeuticsMD
TXMD
$24M
$17.5M 1.38%
134,851
+41,032
+44% +$7.36M
BECN
27
DELISTED
Beacon Roofing Supply, Inc.
BECN
$17.5M 1.38%
+476,219
New +$17.2M
WKC icon
28
World Kinect Corp
WKC
$1.89B
$17.4M 1.37%
482,716
+283,058
+142% +$8.88M
TSN icon
29
Tyson Foods
TSN
$20.1B
$16.1M 1.27%
200,000
-230,700
-54% -$17.8M
CHRS icon
30
Coherus Oncology
CHRS
$192M
$15.5M 1.22%
700,000
-1,940,771
-73% -$33.7M
SMTA
31
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$15.4M 1.21%
1,841,587
– –
CISN
32
DELISTED
Cision Ltd. Ordinary Share
CISN
$15.2M 1.2%
+1,300,000
New +$15.4M
AVYA
33
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$15.2M 1.2%
+1,276,600
New +$19.5M
INSW icon
34
International Seaways
INSW
$4.48B
$11.4M 0.9%
+599,904
New +$11.1M
BDSI
35
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$10.7M 0.84%
2,292,132
– –
LSAK icon
36
Lesaka Technologies
LSAK
$402M
$10.6M 0.83%
2,650,000
+87,800
+3% +$315K
CC icon
37
Chemours
CC
$2.2B
$8.23M 0.65%
+342,922
New +$10.1M
FLXN
38
DELISTED
Flexion Therapeutics, Inc.
FLXN
$7.58M 0.6%
616,473
-101,834
-14% -$1.17M
SEB icon
39
Seaboard Corp
SEB
$4.06B
$7.24M 0.57%
1,750
+87
+5% +$373K
PPC icon
40
Pilgrim's Pride
PPC
$6.31B
$7.2M 0.57%
283,470
-140,935
-33% -$3.65M
ARQL
41
DELISTED
Arqule Inc
ARQL
$6.69M 0.53%
+607,500
New +$4.23M
NTRA icon
42
Natera
NTRA
$45.9B
$5.52M 0.43%
+200,000
New +$4.41M
VKTX icon
43
Viking Therapeutics
VKTX
$4.02B
$5.48M 0.43%
660,000
-150,000
-19% -$1.28M
FOLD
44
DELISTED
Amicus Therapeutics
FOLD
$4.55M 0.36%
365,000
– –
TVTY
45
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$4.2M 0.33%
+255,623
New +$4.93M
ICHR icon
46
Ichor Holdings
ICHR
$2.43B
$4.12M 0.32%
+174,430
New +$4.07M
TROX icon
47
Tronox
TROX
$993M
$3.83M 0.3%
+300,000
New +$3.68M
RVI
48
DELISTED
Retail Value Inc. Common Shares
RVI
$3.68M 0.29%
1,152,390
– –
CMBT
49
CMB.TECH NV
CMBT
$4.67B
$3.3M 0.26%
+350,000
New +$3.18M
KIN
50
DELISTED
Kindred Biosciences, Inc.
KIN
$2.5M 0.2%
300,000
+184,008
+159% +$1.59M
1
2
3 4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2019 Portfolio in Review

As of Q2 2019, Rubric Capital Management (New York) held 79 positions worth $1.27B, up 19% from $1.07B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Rubric Capital Management (New York) deployed $164M of net new capital in Q2 2019, opening 19 new positions and adding to 11 existing holdings. Its largest new stake was Corteva: 1,700,000 shares worth $50.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Coherus Oncology, an estimated $33.7M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2019 buy was Corteva: 1,700,000 shares worth $50.3M.
  • Rubric Capital Management (New York) added most to Conduent in Q2 2019, an estimated $13.4M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2019 reduction was Coherus Oncology, cutting an estimated $33.7M.
  • Rubric Capital Management (New York) fully exited Viatris in Q2 2019, selling an estimated $48.2M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 54% of its $1.27B portfolio in Q2 2019.
  • Rubric Capital Management (New York) opened 19 new positions and closed 25 in Q2 2019.
  • Rubric Capital Management (New York)'s portfolio value rose 19% quarter-over-quarter to $1.27B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2019, filed 13 Aug 2019.